Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus

Completed · Phase 2 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

The purpose of this study is: * To assess the efficacy of Nasulin vs. placebo as indicated by time spent in euglycemia, assessed by continuous glucose monitoring data and serum fructosamine levels in patient volunteers with Type 2 Diabetes. * To asses the safety and tolerability of Nauslin at 50 IU and 100IU doses in patient volunteers with Type 2 Diabetes

Key facts

Study ID

NCT00850096

Run by

CPEX Pharmaceuticals Inc.

People needed

94

Starts

2009-01-01

Expected to finish

2010-03-01

Last updated by the study team

2013-12-13

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with Type 2 diabetes (18 years of age or older)
• Currently treated with basal insulin and OAD(s)
• HbA1c range of 6.5 - 10.
• BMI less than 41

You may not qualify if…

• Multiple daily injections of mealtime insulin
• Regular use of nasal sprays
• Significant nasal pathology
• Employed in a job which required irregular shift or night work

Where it is running

• Radiant Research — Chandler, Arizona, United States
• AMCR Institute, Inc — Escondido, California, United States
• Scripps Whittier Diabetes Clinic — La Jolla, California, United States
• Mills-Penninsula Health Services; Dorothy & Frank Diabetes Inst. — San Mateo, California, United States
• Diablo Clinical Research — Walnut Creek, California, United States
• Barbara Davis Center — Aurora, Colorado, United States
• Clinical Research of West Florida — Clearwater, Florida, United States
• University of Miami Diabetes Research Institute — Miami, Florida, United States
• Metabolic Research Institute — West Palm Beach, Florida, United States
• Atlanta Diabetes Associates — Atlanta, Georgia, United States
• East-West Medical Research Institute — Honolulu, Hawaii, United States
• Rocky Mountain Clinical Research — Idaho Falls, Idaho, United States
• Maine Research Associates — Auburn, Maine, United States
• Washington University — St Louis, Missouri, United States
• University of Rochester — Rochester, New York, United States
• Mountain Diabetes and Endocrine Center — Asheville, North Carolina, United States
• ECU Diabetes Research Center — Greenville, North Carolina, United States
• Physician's East PA — Greenville, North Carolina, United States
• Texas Diabetes and Endocrinology — Austin, Texas, United States
• University of Texas; Southwestern Medical Center — Dallas, Texas, United States
• Rainier Clinical Research — Renton, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.